Teletherapy for deaf kids: a new way to bridge language gaps?
NCT ID NCT04928209
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether speech-language teletherapy can improve language outcomes in deaf or hard-of-hearing children aged 0-27 months. Researchers enrolled 210 children, some publicly insured and some privately insured, and gave some access to an 18-month teletherapy program. The goal was to see if teletherapy could help address language disparities.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- speech-language teletherapy
- What this could lead to
- If it works, this could provide a way to improve speech and language development in deaf or hard-of-hearing children, especially those with limited access to in-person therapy.
- What could go wrong
- This is a completed study, but results may not apply to all children or settings. Teletherapy may not be as effective as in-person care for some families.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
210 people
The number who actually took part.
- Started
-
Jul 2021
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
0 to 27 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 0-27 months; * Hearing loss, as determined by auditory brainstem response (ABR) or behavioral audiometry (average of pure-tone air-conduction hearing thresholds (0.5-4 kHz; PTA) calculated from at least 2 frequencies from ABR (dB eHL) or behavioral audiometry (dB HL)): * bilateral sensorineural, mixed, or permanent conductive hearing loss with better-ear PTA \> 20 dB. * single-sided deafness (unilateral SNHL with PTA \> 70 dB); * unilateral complete aural atresia; or * bilateral auditory-neuropathy spectrum disorder, as determined by ABR. * Primary home language is English or Spanish, determined by electronic medical record or direct parent report. * For children with PTA \> 20 dB, either: * Currently fit with hearing aid or using a cochlear implant; OR * Date identified for hearing-aid fitting or cochlear-implant activation within 3 months of enrollment. Exclusion Criteria: * Family does NOT have the intention to pursue listening and spoken language for their child, based on parent report; * Moderate to severe global developmental delay, as determined by managing audiologist and/or otolaryngologist, based on: * ICD-10 diagnosis code or chart review of medical progress notes indicating global developmental delay; * presence of syndrome known to be associated with this delay (such as Trisomy 21, 22q11 syndrome, or CHARGE syndrome); OR * parent report. * Speech-language teletherapy received through a clinical provider outside of this study at the time of enrollment, based on parent report. * No prognosis for access to sound as determined by managing audiologist and/or otolaryngologist. All children with bilateral severe-to-profound SNHL must have imaging to confirm this criterion prior to enrollment in the study. Children will be excluded if they have bilateral severe-to-profound sensorineural hearing loss and either: * Contraindication to cochlear implantation, OR * Temporal bone abnormalities that lead to great concern for poor cochlear-implant outcomes, including common cavity and/or cochlear nerve deficiency on imaging.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hearing loss are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lucile Packard Children's Hospital Stanford
Palo Alto, California, 94303, United States
-
Rady Children's Hospital - San Diego
San Diego, California, 92123, United States
-
Seattle Children's Hospital
Seattle, Washington, 98145, United States
-
The University of California - San Francisco
San Francisco, California, 94158, United States
-
UCSF Benioff Children's Hospital - Oakland
Oakland, California, 94609, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app replace the clinic for hearing aid tuning?
- 30 years of cochlear implant data could reshape hearing care in china
- Can a new hearing aid strategy cut through the noise?
- Can a new bone conduction implant restore hearing for the long haul?
- Can eye movements reveal the hidden toll of hearing loss?
- A digital helping hand for new hearing aid wearers?